These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19099947)

  • 21. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
    Hunt KJ; Resendez RG; Williams K; Haffner SM; Stern MP;
    Circulation; 2004 Sep; 110(10):1251-7. PubMed ID: 15326061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Impact of metabolic syndrome on cardio-cerebral vascular events in pre-hypertensive population].
    Wu SL; Zhang Y; Ruan CY; Tian Q; Jin C; Li JF; Sun YY; Huang W; Zhong JW; Cai J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):397-401. PubMed ID: 22883090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship of vitamin D status to risk of cardiovascular disease and mortality.
    Skaaby T
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of metabolic syndrome on the risk of cardiovascular disease mortality in the United States and in Japan.
    Liu L; Miura K; Fujiyoshi A; Kadota A; Miyagawa N; Nakamura Y; Ohkubo T; Okayama A; Okamura T; Ueshima H
    Am J Cardiol; 2014 Jan; 113(1):84-9. PubMed ID: 24169008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fatty liver index is associated with increased mortality in subjects referred to coronary angiography.
    Lerchbaum E; Pilz S; Grammer TB; Boehm BO; Stojakovic T; Obermayer-Pietsch B; März W
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1231-8. PubMed ID: 23557879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.
    Hu G; Qiao Q; Tuomilehto J; Balkau B; Borch-Johnsen K; Pyorala K;
    Arch Intern Med; 2004 May; 164(10):1066-76. PubMed ID: 15159263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
    Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
    Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metabolic syndrome and peripheral arterial occlusive disease as indicators for increased cardiovascular risk].
    Diehm C; Darius H; Pittrow D; Allenberg JR; Haberl RL; Mahn M; Tepohl HG; Trampisch HJ; Lange S
    Dtsch Med Wochenschr; 2007 Jan; 132(1-2):15-20. PubMed ID: 17187317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome.
    Ko GT; So WY; Chan NN; Chan WB; Tong PC; Li J; Yeung V; Chow CC; Ozaki R; Ma RC; Cockram CS; Chan JC
    Diabetes Obes Metab; 2006 Jan; 8(1):94-104. PubMed ID: 16367887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality.
    Tsai SP; Wen CP; Chan HT; Chiang PH; Tsai MK; Cheng TY
    Diabetes Res Clin Pract; 2008 Oct; 82(1):148-56. PubMed ID: 18757109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The components of metabolic syndrome that influencing the prevalence of cardiovascular disease in a follow-up study].
    Wan G; Wang BY; Feng J; Lv ZP; Huang H; Hu CY; Yang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Dec; 30(12):1217-20. PubMed ID: 20193300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced cardiovascular mortality risk in male smokers who are physically active. Results from a 25-year follow-up of the prospective population study men born in 1914.
    Hedblad B; Ogren M; Isacsson SO; Janzon L
    Arch Intern Med; 1997 Apr; 157(8):893-9. PubMed ID: 9129549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome, major depression, generalized anxiety disorder, and ten-year all-cause and cardiovascular mortality in middle aged and elderly patients.
    Butnoriene J; Bunevicius A; Saudargiene A; Nemeroff CB; Norkus A; Ciceniene V; Bunevicius R
    Int J Cardiol; 2015; 190():360-6. PubMed ID: 25939128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The separate and combined effects of adiposity and cardiometabolic dysfunction on the risk of recurrent cardiovascular events and mortality in patients with manifest vascular disease.
    van der Leeuw J; van der Graaf Y; Nathoe HM; de Borst GJ; Kappelle LJ; Visseren FL;
    Heart; 2014 Sep; 100(18):1421-9. PubMed ID: 24817441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension as a risk factor for cardiovascular morbidity and mortality in an elderly German population; the prospective STEPHY II study. Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly.
    Trenkwalder P; Hendricks P; Schöniger R; Rossberg J; Lydtin H; Hense HW
    Eur Heart J; 1999 Dec; 20(23):1752-6. PubMed ID: 10562484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic senile gait disorders are signs of subclinical disease.
    Bloem BR; Gussekloo J; Lagaay AM; Remarque EJ; Haan J; Westendorp RG
    J Am Geriatr Soc; 2000 Sep; 48(9):1098-101. PubMed ID: 10983910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients.
    Monami M; Marchionni N; Masotti G; Mannucci E
    Diabetes Obes Metab; 2007 May; 9(3):350-3. PubMed ID: 17391162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revised Adult Treatment Panel III guidelines and cardiovascular disease mortality in men attending a preventive medical clinic.
    Ardern CI; Katzmarzyk PT; Janssen I; Church TS; Blair SN
    Circulation; 2005 Sep; 112(10):1478-85. PubMed ID: 16129792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men.
    Katzmarzyk PT; Church TS; Blair SN
    Arch Intern Med; 2004 May; 164(10):1092-7. PubMed ID: 15159266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.